Aug 12, 2020 | Laboratory Pathology
Though lenders and landlords may be willing to renegotiate terms, communication is key, the lawyers suggest COVID-19 has vastly increased demand for clinical laboratory testing. But at many labs, the pandemic has caused much damage to the bottom line. Due to numerous factors—including reductions in elective procedures and increased operating costs—many independent lab companies have seen a 30% to 60% cut in revenue, says attorney Richard S. Cooper, JD, of McDonald Hopkins, a law firm that...
